118 related articles for article (PubMed ID: 16056259)
1. The TCL1 family of oncoproteins: co-activators of transformation.
Teitell MA
Nat Rev Cancer; 2005 Aug; 5(8):640-8. PubMed ID: 16056259
[TBL] [Abstract][Full Text] [Related]
2. The role of TCL1 in human T-cell leukemia.
Pekarsky Y; Hallas C; Croce CM
Oncogene; 2001 Sep; 20(40):5638-43. PubMed ID: 11607815
[TBL] [Abstract][Full Text] [Related]
3. Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice.
Zanesi N; Aqeilan R; Drusco A; Kaou M; Sevignani C; Costinean S; Bortesi L; La Rocca G; Koldovsky P; Volinia S; Mancini R; Calin G; Scott CP; Pekarsky Y; Croce CM
Cancer Res; 2006 Jan; 66(2):915-20. PubMed ID: 16424025
[TBL] [Abstract][Full Text] [Related]
4. TCL1 in B-cell tumors retains its normal b-cell pattern of regulation and is a marker of differentiation stage.
Herling M; Patel KA; Hsi ED; Chang KC; Rassidakis GZ; Ford R; Jones D
Am J Surg Pathol; 2007 Jul; 31(7):1123-9. PubMed ID: 17592280
[TBL] [Abstract][Full Text] [Related]
5. TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphoma.
Teitell MA; Lones MA; Perkins SL; Sanger WG; Cairo MS; Said JW
Am J Clin Pathol; 2005 Oct; 124(4):569-75. PubMed ID: 16146820
[TBL] [Abstract][Full Text] [Related]
6. The Tcl1 oncogene defines secondary hair germ cells differentiation at catagen-telogen transition and affects stem-cell marker CD34 expression.
Ragone G; Bresin A; Piermarini F; Lazzeri C; Picchio MC; Remotti D; Kang SM; Cooper MD; Croce CM; Narducci MG; Russo G
Oncogene; 2009 Mar; 28(10):1329-38. PubMed ID: 19169282
[TBL] [Abstract][Full Text] [Related]
7. The TCL1 oncoprotein binds the RNase PH domains of the PNPase exoribonuclease without affecting its RNA degrading activity.
French SW; Dawson DW; Chen HW; Rainey RN; Sievers SA; Balatoni CE; Wong L; Troke JJ; Nguyen MT; Koehler CM; Teitell MA
Cancer Lett; 2007 Apr; 248(2):198-210. PubMed ID: 16934922
[TBL] [Abstract][Full Text] [Related]
8. [Transgenic mice expressing MTCP1: an animal model for T-cell prolymphocytic leukemia].
Chiali-Gritti C
Ann Pharm Fr; 2000 Jan; 58(1):54-61. PubMed ID: 10669814
[TBL] [Abstract][Full Text] [Related]
9. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
[TBL] [Abstract][Full Text] [Related]
10. Tcl1 as a model for lymphomagenesis.
Pekarsky Y; Zanesi N; Aqeilan R; Croce CM
Hematol Oncol Clin North Am; 2004 Aug; 18(4):863-79, ix. PubMed ID: 15325703
[TBL] [Abstract][Full Text] [Related]
11. Distinct response in maintenance of human naive and memory B cells via IL-21 receptor and TCL1/Akt pathways.
Nagumo H; Abe J; Kano H; Taki S; Yamazaki K; Yamazaki T; Kobayashi N; Koike K; Sugane K; Saito H; Agematsu K
Cell Immunol; 2009; 256(1-2):56-63. PubMed ID: 19230867
[TBL] [Abstract][Full Text] [Related]
12. Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3.
Su X; Drabkin H; Clappier E; Morgado E; Busson M; Romana S; Soulier J; Berger R; Bernard OA; Lavau C
Genes Chromosomes Cancer; 2006 Sep; 45(9):846-55. PubMed ID: 16804919
[TBL] [Abstract][Full Text] [Related]
13. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1.
Rosenbauer F; Owens BM; Yu L; Tumang JR; Steidl U; Kutok JL; Clayton LK; Wagner K; Scheller M; Iwasaki H; Liu C; Hackanson B; Akashi K; Leutz A; Rothstein TL; Plass C; Tenen DG
Nat Genet; 2006 Jan; 38(1):27-37. PubMed ID: 16311598
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of Tcl1 family oncoproteins and their conserved surface features.
Petock JM; Torshin IY; Wang YF; Du Bois GC; Croce CM; Harrison RW; Weber IT
ScientificWorldJournal; 2002 Jul; 2():1876-84. PubMed ID: 12920316
[TBL] [Abstract][Full Text] [Related]
15. Expression of TCL1 and CD27 in primary cutaneous B-cell lymphomas.
Pescarmona E; Remotti D; Perez M; Monaco S; Pacchiarotti A; Faraggiana T; Russo G; Baroni CD
Histopathology; 2006 Oct; 49(4):343-8. PubMed ID: 16978196
[TBL] [Abstract][Full Text] [Related]
16. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
17. The TCL1 mouse as a model for chronic lymphocytic leukemia.
Hamblin TJ
Leuk Res; 2010 Feb; 34(2):135-6. PubMed ID: 19726084
[TBL] [Abstract][Full Text] [Related]
18. SRC-3 is required for prostate cancer cell proliferation and survival.
Zhou HJ; Yan J; Luo W; Ayala G; Lin SH; Erdem H; Ittmann M; Tsai SY; Tsai MJ
Cancer Res; 2005 Sep; 65(17):7976-83. PubMed ID: 16140970
[TBL] [Abstract][Full Text] [Related]
19. Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation.
Rodig SJ; Vergilio JA; Shahsafaei A; Dorfman DM
Am J Surg Pathol; 2008 Jan; 32(1):113-22. PubMed ID: 18162778
[TBL] [Abstract][Full Text] [Related]
20. The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCtheta and ERK pathways.
Despouy G; Joiner M; Le Toriellec E; Weil R; Stern MH
Blood; 2007 Dec; 110(13):4406-16. PubMed ID: 17846228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
